Pharma Journalist 9057 posts 0 comments

Novo Nordisk has unveiled a major rebrand as it begins what the company describes as its next chapter, introducing the single name “Novo” and a new brand platform built around the…
Read More...

Schrödinger has launched a new biotechnology company, Tectora, to develop potential treatments for immunology and inflammatory diseases. The company was co-founded by Schrödinger, New…
Read More...

CordenPharma is investing €80 million to expand its sterile injectable manufacturing capabilities at its Caponago site near Milan, Italy. The long-term investment program includes…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Bayer’s HYRNUO (sevabertinib) as a first-line treatment for adults with locally advanced or metastatic…
Read More...

Encoded Therapeutics has raised $275 million in a new financing round to advance its genetic medicine programs for severe neurological disorders, including its lead candidate ETX101 for…
Read More...

Exegenesis Bio and Modalis Therapeutics have entered a research collaboration and license agreement to advance MDL-201, an experimental treatment candidate for Duchenne muscular…
Read More...

Leading model-informed drug development experts to unite in Boston to explore pharmacometrics, AI, quantitative systems pharmacology, and evolving regulatory expectations The 2nd…
Read More...

With one week remaining until the 4th TRP Supply Chain & Manufacturing Summit, senior leaders from across the radiopharmaceutical industry are preparing to gather in Boston to…
Read More...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca’s Etcamah (camizestrant) for certain adults with advanced breast cancer, expanding treatment…
Read More...

AtomVie Global Radiopharma (AtomVie) has officially opened a new radiopharmaceutical manufacturing facility in Hamilton, Ontario, marking a major expansion of its production…
Read More...